Related references
Note: Only part of the references are listed.Shrunken pore syndrome - a common kidney disorder with high mortality. Diagnosis, prevalence, pathophysiology and treatment options
Anders Grubb
CLINICAL BIOCHEMISTRY (2020)
The mortality increase in cardiac surgery patients associated with shrunken pore syndrome correlates with the eGFRcystatin C/eGFRcreatinine-ratio
Erik Herou et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2019)
Shrunken Pore Syndrome Is Associated With Increased Levels of Atherosclerosis-Promoting Proteins
Markus Sallman Almen et al.
KIDNEY INTERNATIONAL REPORTS (2019)
The cystatin C/creatinine ratio, a marker of glomerular filtration quality: associated factors, reference intervals, and prediction of morbidity and mortality in healthy seniors
Mette-Triin Purde et al.
TRANSLATIONAL RESEARCH (2016)
The association between serum cystatin C and carotid intima-media thickness in metabolic syndrome patients with normal estimated glomerular filtration rate
Rong Huang et al.
CLINICA CHIMICA ACTA (2015)
Cardiovascular disease and chronic kidney disease
Richard Gargiulo et al.
DM DISEASE-A-MONTH (2015)
Reduction in glomerular pore size is not restricted to pregnant women. Evidence for a new syndrome: 'Shrunken pore syndrome'
Anders Grubb et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2015)
Measuring GFR: A Systematic Review
Inga Soveri et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2014)
Clinical utility of brachial-ankle pulse wave velocity in the prediction of cardiovascular events in diabetic patients
Naoto Katakami et al.
CARDIOVASCULAR DIABETOLOGY (2014)
Generation of a New Cystatin C-Based Estimating Equation for Glomerular Filtration Rate by Use of 7 Assays Standardized to the International Calibrator
Anders Grubb et al.
CLINICAL CHEMISTRY (2014)
The Role of Carotid Intimal Thickness and Plaque Imaging in Risk Stratification for Coronary Heart Disease
Smita I. Negi et al.
CURRENT ATHEROSCLEROSIS REPORTS (2012)
Cystatin C, Albuminuria, and Mortality Among Older Adults With Diabetes
Ian H. de Boer et al.
DIABETES CARE (2009)
Thiazide Effects and Adverse Effects Insights From Molecular Genetics
David H. Ellison et al.
HYPERTENSION (2009)
Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population
Brad C. Astor et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Ankle Brachial Index Combined With Framingham Risk Score to Predict Cardiovascular Events and Mortality
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease
Michael G. Shlipak et al.
ANNALS OF INTERNAL MEDICINE (2006)
Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: More than simply a marker of glomerular filtration rate
W Koenig et al.
CLINICAL CHEMISTRY (2005)
Cystatin-C and mortality in elderly persons with heart failure
MG Shlipak et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
AS Go et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Evidence for increased cardiovascular disease risk in patients with chronic kidney disease
J Coresh et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2004)
Glomerular filtration rate dependence of sieving of albumin and some neutral proteins in rat kidneys
U Lund et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2003)